CARSGEN THERAPEUTICS
CARsgen is a leading clinical-stage immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has partnership with Shanghai Cancer Institute and Shanghai Renji Hospital. The company is leading the first tier of CAR-T development, by completing Worldโs first hepatocellular carcinoma (HCC) and Chinaโs exclusive glioblastoma multiforme (GBM) dose ascending injection tests. Funded by leading venture capital firm BVCF, CARsgen is well-positioned to bring a novel cancer therapeutics to the market in China and worldwide.
CARSGEN THERAPEUTICS
Social Links:
Industry:
Health Diagnostics Medical Therapeutics
Founded:
2014-11-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.carsgen.com
Total Employee:
11+
Status:
Active
Contact:
+862154489928
Email Addresses:
[email protected]
Total Funding:
276 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Font Awesome Global Site Tag Euro Microsoft Exchange Online
Similar Organizations
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Employees Featured
Founder
Investors List
Loyal Valley Capital
Loyal Valley Capital investment in Series C - CARsgen Therapeutics
South China Venture Capital
South China Venture Capital investment in Series C - CARsgen Therapeutics
Shiyu Capital
Shiyu Capital investment in Series C - CARsgen Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - CARsgen Therapeutics
Summer Capital
Summer Capital investment in Series C - CARsgen Therapeutics
KTB Ventures
KTB Ventures investment in Series C - CARsgen Therapeutics
Jolly Innovation Ventures
Jolly Innovation Ventures investment in Series C - CARsgen Therapeutics
Photon Fund
Photon Fund investment in Series C - CARsgen Therapeutics
Kaitai Capital
Kaitai Capital investment in Series B - CARsgen Therapeutics
JIC Genesis Fountain Healthcare Ventures
JIC Genesis Fountain Healthcare Ventures investment in Series B - CARsgen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-02 | CARsgen Appoints Dr. Hua Jiang as Executive Director |
| 2022-04-07 | CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer |
| 2022-01-17 | CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation |
Official Site Inspections
http://www.carsgen.com Semrush global rank: 2.34 M Semrush visits lastest month: 7.95 K
Unable to get host informations!!!
More informations about "CARsgen Therapeutics"
Company Overview - CARsgen
CARsgen is a biopharmaceutical company with operations in China and the U.S. and is โฆSee details»
CARsgen Therapeutics - Crunchbase Company Profile โฆ
CARsgen is a leading clinical-stage immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for โฆSee details»
Vision / Mission / Values | CARsgen
CARsgenโs mission is to become a global biopharmaceutical leader that provides innovative โฆSee details»
CARsgen Therapeutics - Funding, Financials, Valuation & Investors
CARsgen Therapeutics is registered under the ticker HKG:2171 . Their stock opened with โฆSee details»
CARsgen Therapeutics - Contacts, Employees, Board Members, โฆ
CARsgen Therapeutics has 3 current employee profiles, including Chief Medical Officer โฆSee details»
Carsgen Therapeutics - EverybodyWiki Bios & Wiki
In October 2022, Carsgen announced that the National Medical Products Administration โฆSee details»
CARsgen Therapeutics - The Org
CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. Industries. Biotechnology. Headquarters. โฆSee details»
Jia Jie - VP, Strategic Alliances & Operations at โฆ
Dr. Jia has served in CARsgen Therapeutics Corporation, the wholly-owned subsidiary incorporated in the United States since joining the Group, including as the Vice President, Business Development responsible for overseeing the โฆSee details»
Corporate Governance | CARsgen
Procedures for shareholders to propose a person for election as a director of the companySee details»
CARsgen - VentureRadar
" CARsgen is a leading immunotherapy company focused on the development of new chimeric โฆSee details»
CARsgenโs Competitors, Revenue, Number of Employees, Funding โฆ
CARsgen: CARsgen Therapeutics Holdings Limited Reports Earnings Results for the Half Year โฆSee details»
CARsgen Therapeutics - Updates, News, Events, Signals & Triggers
CARsgen is a leading immunotherapy company focused on the development of new chimeric โฆSee details»
CARsgen Therapeutics - Overview, News & Similar companies
Apr 7, 2022 CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 โฆSee details»
CARsgen® U.S. Clinical Holds Lifted by FDA - Yahoo Finance
Nov 1, 2024 CARsgen is a biopharmaceutical company with operations in China and the โฆSee details»
CARsgen Announced 2022 Annual Results and Business Updates
SHANGHAI, March 22, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock โฆSee details»
Financial Reports - CARsgen
2023 Annual Report. Read More. Sep 2023See details»
CARsgen® U.S. Clinical Holds Lifted by FDA - Morningstar
Nov 1, 2024 CARsgen has established a comprehensive CAR T-cell research and โฆSee details»
ไธป้กต | CARsgen
ๆไปฌ็ๆฟๆฏๆฏๆไธบๅ จ็็็ฉๅถ่ฏ้ขๅฏผ่ ๏ผไธบๅ จ็็็ๆฃ่ ๅธฆๆฅๅๆฐๅๅทฎๅผๅ็็ป่็ๆณ๏ผๅนถไฝฟ็ โฆSee details»
Newsroom | CARsgen
3 days ago CARsgen is a biopharmaceutical company with operations in China and the U.S., โฆSee details»